AJ502

AJ502 is a novel, potent, and selective PDE4 inhibitor that has good skin permeating characteristics.

Topically administered AJ502 showed efficacy in IMQ-induced psoriasis and PMA-induced atopic dermatitis in the animal models superior to that of marketed comparators. AJ502 is at IND-enabling stage.

Current Pipeline

  • 60% 60%
  • 40% 40%
  • 30% 30%
  • 15% 15%
  • 10% 10%

Contact

We look forward to further discussions with you.
Please fill out the form, and we will get right back to you.

+886-02-2365-5677

info@ajpharm.com

B405, No. 18, Siyuan St., Zhongzheng Dist., Taipei City 100, Taiwan (R.O.C.)

4 + 9 =